|
C13ORF37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.106800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.110000E-01 |
| Normal-vs-Stage2 |
2.566600E-01 |
| Normal-vs-Stage3 |
7.306000E-01 |
| Normal-vs-Stage4 |
9.838400E-01 |
| Stage1-vs-Stage2 |
1.163550E-01 |
| Stage1-vs-Stage3 |
8.711600E-01 |
| Stage1-vs-Stage4 |
8.429200E-01 |
| Stage2-vs-Stage3 |
1.525410E-01 |
| Stage2-vs-Stage4 |
3.211400E-01 |
| Stage3-vs-Stage4 |
7.891000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.639000E-01 |
| Normal-vs-AfricanAmerican |
8.253800E-01 |
| Normal-vs-Asian |
8.519200E-01 |
| Caucasian-vs-AfricanAmerican |
7.291800E-01 |
| Caucasian-vs-Asian |
7.095000E-01 |
| AfricanAmerican-vs-Asian |
9.537000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.218400E-01 |
| Normal-vs-Female |
6.273800E-01 |
| Male-vs-Female |
5.958100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.113200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.030400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.175800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.533200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.662400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.963400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.024800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.291600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.726960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.372800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.209800E-01 |
| Classical-VS-Follicular |
1.647000E-01 |
| Classical-VS-Other |
2.982600E-01 |
| Classical-VS-Normal |
5.983000E-01 |
| Tall-VS-Follicular |
1.736040E-01 |
| Tall-VS-Other |
1.955050E-01 |
| Tall-VS-Normal |
3.330000E-01 |
| Follicular-VS-Other |
5.829200E-01 |
| Follicular-VS-Normal |
5.916200E-01 |
| Other-VS-Normal |
3.513800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.817600E-01 |
| Normal-vs-N1 |
7.614200E-01 |
| N0-vs-N1 |
3.028000E-01 |
|
|
